Beta-glucan and diphtheria toxoid combination significantly augments IL-21 and sCD14 in systemic aspergillosis

Systemic fungal infections, particularly by Aspergillus fumigatus, pose a severe threat to immunocompromised patients, often leading to high mortality rates. Current antifungal therapies frequently fall short, necessitating novel immunomodulatory strategies that can bolster both innate and adaptive immune responses. This study explores beta-glucans, known fungal immunomodulators, and diphtheria toxoid (DT), recognized for its non-specific immune-stimulatory properties, as potential agents to enhance host defense by targeting markers like soluble CD14 (sCD14) for innate immunity and interleukin-21 (IL-21) for adaptive immunity.

Researchers investigated the immunomodulatory effects of beta-glucan, biphasic beta-glucan, and diphtheria toxoid (DT), alone and in combination, in a model of systemic fungal infection. 50 male albino rats were challenged with a systemic injection of A. fumigatus. The study measured serum IL-21 and sCD14 levels on day 21 post-challenge using enzyme-linked immunosorbent assay (ELISA) kits. Control groups received no immunomodulatory treatment, allowing for direct comparison of the interventions' impact on immune markers.

The study revealed a significant enhancement of key immune markers in response to the interventions. The beta-glucan group demonstrated a significant increase in both IL-21 and sCD14 levels compared to the control group, indicating a bolstered immune response. However, the combination of beta-glucan + DT exhibited the most potent immunomodulatory effect, leading to the highest observed levels of both markers. This synergistic action suggests a more robust activation of host defense mechanisms. Specifically, IL-21, a cytokine crucial for T-cell differentiation and B-cell proliferation, was elevated, alongside sCD14, a marker associated with innate immune activation and pathogen recognition. The combined treatment's superior efficacy points towards a comprehensive activation of both adaptive and innate immune pathways. The abstract did not provide specific numerical values for the increases or p-values, but consistently described the effects as "significant increase" and "most potent effect".